Atypische Mykobakterien

  • C. Schieferstein


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bennett C, Vardiman J, Golomb H (1986) Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med 80(5): 891–896PubMedCrossRefGoogle Scholar
  2. Benson CA, Ellner JJ (1993) Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin Infect Dis 17(1): 7–20PubMedGoogle Scholar
  3. Benson CA, Williams PL, Currier JS et al. (2003) A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons. Clin Infect Dis 37: 1234–1243PubMedCrossRefGoogle Scholar
  4. Brodt HR, Enzensberger R, Kamps BS et al. (1997) Impact of disseminated Mycobacterium avium-complex infection on survival of HIV-infected patients. Eur J Med Res 2(3): 106–110PubMedGoogle Scholar
  5. Chapman, JS (1971) The ecology of the atypical mycobacteria. Arch Environ Health 22: 41PubMedGoogle Scholar
  6. Chin DP, Hopewell PC, Yajko DM et al. (1994) Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis 169(2): 289–295PubMedGoogle Scholar
  7. Crowe SM, Carlin JB, Stewart KI et al. (1991) Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 4(8): 770–776PubMedGoogle Scholar
  8. Debrunner M, Salfinger M, Brandli O et al. (1992) Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 15: 330PubMedGoogle Scholar
  9. Goslee S, Wolinsky E. (1976) Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis 113: 287PubMedGoogle Scholar
  10. Greene JB, Sidhu GS, Lewin S et al. (1982) Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med 97(4): 539–546PubMedGoogle Scholar
  11. Havlik JA jr., Horsburgh CR jr, Metchock B et al. (1992) Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends. J Infect Dis 165(3): 577–580PubMedGoogle Scholar
  12. Hoffmann C (2005) Atypische Mykobakteriose (MAC) 2005. In: Hoffmann, Rockstroh, Kamps (Hrsg) HIV.NET 2005. Steinhäuser, Wuppertal. http: // Scholar
  13. Horsburgh CR jr (1999) The pathophysiology of disseminated Mycobacterium avium complex disease in AIDS. J Infect Dis, Suppl 3: S461–465CrossRefGoogle Scholar
  14. Horsburgh CR jr, Nelson AM (2002) Mycobacterial disease of the gastrointestinal tract. In: Blaser J, Ravdin JI, Smith PD, Greenberg HB, Guerrant LR (eds) Infections of the gastrointestinal tract, 2nd ed. Lippincott Williams & Wilkins, pp 831–846Google Scholar
  15. Kalayjian RC, Toossi Z, Tomashefski JF jr et al. (1995) Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS. Clin Infect Dis 20(5): 1186–1194PubMedGoogle Scholar
  16. Karakousis PC, Moore RD, Chaisson RE (2004) Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis 4(9): 557–565PubMedCrossRefGoogle Scholar
  17. Katoch VM (2004) Infections due to non-tuberculous mycobacteria (NTM). Indian J Med Res 120(4): 290–304PubMedGoogle Scholar
  18. Klein JL, Corbett EL, Slade PM et al. (1998) Mycobacterium kansasii and human immunodeficiency virus co-infection in London. J Infect 37(3): 252–259PubMedCrossRefGoogle Scholar
  19. Lange CG, Woolley IJ, Brodt RH (2004) Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated? Drugs 64(7): 679–692PubMedCrossRefGoogle Scholar
  20. Lundgren JD, Phillips AN, Vella S et al. (1997) Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 16: 153–160PubMedGoogle Scholar
  21. Macher AM, Kovacs JA, Gill V et al. (1983) Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med 99(6): 782–785PubMedGoogle Scholar
  22. O’Brien RJ, Geiter LJ, Snider DE (1987) The epidemiology of nontuberculous mycobacterial diseases in the United States: Results from a national survey. Am Rev Respir Dis 135: 1007PubMedGoogle Scholar
  23. Stille W, Brodt HR, Groll AH, Just-Nübling G (Hrsg) (2005) Mykobakterien-Infektionen. In: Antibiotika-Therapie. 11. Aufl. Schauttauer, StuttgartGoogle Scholar
  24. Ward TT, Rimland D, Kauffman C et al. (1998) Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with HIV infection. Clin Infect Dis 27: 1278–1285PubMedGoogle Scholar
  25. Weinstein RA, Golomb HM, Grumet G et al. (1981) Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer 48(2): 380–383PubMedCrossRefGoogle Scholar
  26. Wolinsky E (1992) Mycobacterial diseases other than tuberculosis. Clin Infect Dis 15(1): 1–10PubMedGoogle Scholar
  27. Wolinsky E, Rynearson TK (1968) Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 7: 1032Google Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2006

Authors and Affiliations

  • C. Schieferstein
    • 1
  1. 1.Medizinische Klinik I, Klinikum der Johann WolfgangGoethe-UniversitätFrankfurt am Main

Personalised recommendations